Histological characteristics of radical prostatectomy specimens in men with a serum prostate specific antigen of 4 ng./ml. or less

Journal of Urology

Volumn 155, Issue 2, 1996, Pages 441-443

  Noldus, Joachim ^a   Stamey, Thomas A ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

antigens, neoplasm; prostate specific antigen; prostatectomy; prostatic neoplasms

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ANTIGEN DETECTION; ARTICLE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; PROSTATECTOMY; TREATMENT OUTCOME; TUMOR BIOPSY; TUMOR VOLUME;

EID: 0030045323     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)66412-7     Document Type: Article

References (23)

1. Iwakiri, J., Grandbois, K., Wehner, N., Graves, H. C. B. and Stamey, T.: An analysis of urinary prostate specific antigen before and after radical prostatectomy: evidence for secretion of prostate specific antigen by the periurethral glands. J. Urol., 149: 783, 1993.
2. Oesterling, J. E., Chan, D. W., Epstein, J. I., Kimball, A. W., Jr., Bruzek, D. J., Rock, R. C., Brendler, C. B. and Walsh, P. C.: Prostate specific antigen in the preoperative and postoperative evaluation of localized prostatic cancer treated with radical prostatectomy. J. Urol., 139: 766, 1988.
3. Hara, M., Koyanagi, Y. and Inoue, T.: Some physico-chemical characteristics of "gamma-seminoprotein", an antigenic component specific for human seminal plasma. Forensic immunological study of body fluids and secretion. Jap. J. Legal Med., 25: 322, 1971.
4. Wang, M. C., Valenzuela, L. A., Murphy, G. P. and Chu, T. M.: Purification of a human prostate specific antigen. Invest. Urol., 17: 159, 1979.
5. Stamey, T. A., Kabalin, J. N., McNeal, J. E., Johnstone, I. M., Freiha, F., Redwine, E. A. and Yang, N.: Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. II. Radical prostatectomy treated patients. J. Urol., 141: 1076, 1989.
6. Stamey, T. A., Kabalin, J. N., Ferrari, M. and Yang, N.: Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. IV. Anti-androgen treated patients. J. Urol., 141: 1088, 1989.
7. Link, P., Freiha, F. S. and Stamey, T. A.: Adjuvant radiation therapy in patients with detectable prostate specific antigen following radical prostatectomy. J. Urol., 145: 532, 1991.
8. Stamey, T. A., Kabalin, J. N. and Ferrari, M.: Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. III. Radiation treated patients. J. Urol., 141: 1084, 1989.
9. Ohori, M., Wheeler, T. M. and Scardino, P. T.: The new American Joint Committee on Cancer and International Union Against Cancer TNM classification of prostate cancer. Clinicopathologic correlations. Cancer, 74: 104, 1994.
10. Partin, A. W., Pound, C. R., Clemens, J. Q., Epstein, J. I. and Walsh, P. C.: Serum PSA after anatomic radical prostatectomy. The Johns Hopkins experience after 10 years. Urol. Clin. N. Amer., 20: 713, 1993.
11. Dalkin, B. L., Ahmann, F. R. and Kopp, J. B.: Prostate specific antigen levels in men older than 50 years without clinical evidence of prostatic carcinoma. J. Urol., 150: 1837, 1993.
12. Oesterling, J. E., Jacobsen, S. J., Chute, C. G., Guess, H. A., Girman, C. J., Panser, L. A. and Lieber, M. M.: Serum prostate-specific antigen in a community-based population of healthy men. Establishment of age-specific reference ranges. J.A.M.A., 270: 860, 1993.
13. Stamey, T. A., McNeal, J. E., Freiha, F. S. and Redwine, E.: Morphometric and clinical studies on 68 consecutive radical prostatectomies. J. Urol., 139: 1235, 1988.
14. McNeal, J. E., Villers, A. A., Redwine, E. A., Freiha, F. S. and Stamey, T. A.: Histologic differentiation, cancer volume, and pelvic lymph node metastasis in adenocarcinoma of the prostate. Cancer, 66: 1225, 1990.
15. Stamey, T. A., Yang, N., Hay, A. R., McNeal, J. E., Freiha, F. S. and Redwine, E.: Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. New Engl. J. Med., 317: 909, 1987.
16. Lange, P. H., Ercole, C. J., Lightner, D. J., Fraley, E. E. and Vessella, R.: The value of serum prostate specific antigen determinations before and after radical prostatectomy. J. Urol., 141: 873, 1989.
17. Partin, A. W., Carter, H. B., Chan, D. W., Epstein, J. I., Oesterling, J. E., Rock, R. C., Weber, J. P. and Walsh, P. C.: Prostate specific antigen in the staging of localized prostate cancer: influence of tumor differentiation, tumor volume and benign hyperplasia. J. Urol., 143: 747, 1990.
18. Franks, L. M.: Latent carcinoma of the prostate. J. Path. Bact., 68: 603, 1954.
19. Stamey, T. A., Freiha, F. S., McNeal, J. E., Redwine, E. A., Whittemore, A. S. and Schmid, H. P.: Localized prostate cancer. Relationship of tumor volume to clinical significance for treatment of prostate cancer. Cancer, suppl., 71: 933, 1993.
20. Schmid, H. P., McNeal, J. E. and Stamey, T. A.: Observations on the doubling time of prostate cancer. The use of serial prostate-specific antigen in patients with untreated disease as a measure of increasing cancer volume. Cancer, 71: 2031, 1993.
21. Dietrick, D. D., McNeal, J. E. and Stamey, T. A.: Core cancer length in ultrasound-guided systematic, sextant biopsies: a preoperative evaluation of prostate cancer volume. Urology, 45: 987, 1995.
22. Bluestein, D. L., Bostwick, D. G., Bergstralh, E. J. and Oesterling, J. E.: Eliminating the need for bilateral pelvic lymphadenectomy in select patients with prostate cancer. J. Urol., 151: 1315, 1994.
23. Cisek, L. J. and Walsh, P. C.: Thromboembolic complications following radical retropubic prostatectomy. Influence of external sequential pneumatic compression devices. Urology, 42: 406, 1993.